In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

The British Horseracing Authority (BHA) has today published the following updates regarding medication control. This includes ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chro ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Consumer Reports has no financial relationship with any advertisers on this site.

Colorful dyes, chemical preservatives, and other once-common additives are now banned in many parts of the world as we better ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.